DOI:
10.1055/s-00000025
Hormone and Metabolic Research
LinksClose Window
References
Brose MS, Nutting CM, Jarzab B, Elisei R, Siena S, Bastholt L, de la Fouchardiere C, Pacini F, Paschke R, Shong YK, Sherman SI, Smit JW, Chung J, Kappeler C, Pena C, Molnar I, Schlumberger MJ.
Sorafenib in radioactive iodine-refractory, locally advanced or metastatic differentiated thyroid cancer: A randomised, double-blind, phase 3 trial.
Lancet 2014;
384: 319-328
Access:
Access:
Access:
We do not assume any responsibility for the contents of the web pages of other providers.